Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

ClinicalTrials.gov ID: NCT01940900

Public ClinicalTrials.gov record NCT01940900. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Administration of Fovista® (Anti PDGF-B Pegylated Aptamer) Administered in Combination With Lucentis® Compared to Lucentis® Monotherapy in Subjects With Subfoveal Neovascular Age-related Macular Degeneration.

Study identification

NCT ID
NCT01940900
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ophthotech Corporation
Industry
Enrollment
627 participants

Conditions and interventions

Interventions

  • E10030 Drug
  • ranibizumab Drug
  • E10030 sham intravitreal injection Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2013
Primary completion
Nov 30, 2016
Completion
Nov 30, 2016
Last update posted
Oct 29, 2024

2013 – 2016

United States locations

U.S. sites
49
U.S. states
23
U.S. cities
46
Facility City State ZIP Site status
Not listed Tucson Arizona 85704
Not listed Tucson Arizona 85710
Not listed Fresno California 93720
Not listed La Jolla California 92093
Not listed Loma Linda California 92354
Not listed Mountain View California 94040
Not listed Sacramento California 95819
Not listed Santa Ana California 92705
Not listed Aurora Colorado 80045
Not listed Golden Colorado 80401
Not listed Boynton Beach Florida 33426
Not listed Fort Lauderdale Florida 33308
Not listed Fort Myers Florida 33912
Not listed Largo Florida 33770
Not listed Orlando Florida 32806
Not listed Atlanta Georgia 30322
Not listed Augusta Georgia 30909
Not listed Harvey Illinois 60426
Not listed West Des Moines Iowa 50266
Not listed Shawnee Mission Kansas 66204
Not listed Wichita Kansas 67214
Not listed Baltimore Maryland 21209
Not listed Hagerstown Maryland 21740
Not listed Peabody Massachusetts 01960
Not listed Worcester Massachusetts 01605
Not listed Minneapolis Minnesota 55435
Not listed Lawrenceville New Jersey 08648
Not listed New York New York 10022
Not listed Syracuse New York 13224
Not listed Asheville North Carolina 28803
Not listed Charlotte North Carolina 28210
Not listed Winston-Salem North Carolina 27157
Not listed Cleveland Ohio 44122
Not listed Cleveland Ohio 44130
Not listed Oklahoma City Oklahoma 73104
Not listed Greenville South Carolina 29605
Not listed West Columbia South Carolina 29169
Not listed Rapid City South Dakota 57701
Not listed Nashville Tennessee 37203
Not listed Austin Texas 78705
Not listed Dallas Texas 75231
Not listed Houston Texas 77030
Not listed McAllen Texas 78503
Not listed San Antonio Texas 78233
Not listed San Antonio Texas 78240
Not listed Salt Lake City Utah 84107
Not listed Richmond Virginia 23226
Not listed Virginia Beach Virginia 23454
Not listed Bellevue Washington 98004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01940900, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01940900 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →